DVS: Blood cancer detection using novel CNN-based ensemble approach

Abstract

Blood cancer can only be diagnosed properly if it is detected early. Each year, more than 1.24 million new cases of blood cancer are reported worldwide. There are about 6,000 cancers worldwide due to this disease. The importance of cancer detection and classification has prompted researchers to evaluate Deep Convolutional Neural Networks for the purpose of classifying blood cancers. The objective of this research is to conduct an in-depth investigation of the efficacy and suitability of modern Convolutional Neural Network (CNN) architectures for the detection and classification of blood malignancies. The study focuses on investigating the potential of Deep Convolutional Neural Networks (D-CNNs), comprising not only the foundational CNN models but also those improved through transfer learning methods and incorporated into ensemble strategies, to detect diverse forms of blood cancer with a high degree of accuracy. This paper provides a comprehensive investigation into five deep learning architectures derived from CNNs. These models, namely VGG19, ResNet152v2, SEresNet152, ResNet101, and DenseNet201, integrate ensemble learning techniques with transfer learning strategies. A comparison of DenseNet201 (98.08%), VGG19 (96.94%), and SEresNet152 (90.93%) shows that DVS outperforms CNN. With transfer learning, DenseNet201 had 95.00% accuracy, VGG19 had 72.29%, and SEresNet152 had 94.16%. In the study, the ensemble DVS model achieved 98.76% accuracy. Based on our study, the ensemble DVS model is the best for detecting and classifying blood cancers.